36 results
Thumbnail

D1.125 - Smartphone-Based Asthma Monitoring Using an Audio-Assisted Mouthpiece and STFT-VGG19 Deep Learning Model

Thumbnail

D1.132 - Novel CD8+CD122+ Regulatory T Cells Induced by B Cells Suppress T helper 2 Response and Attenuate Eosinophilic Infiltration in Allergic Asthma

Thumbnail

D1.123 - Visualization of neutrophil extracellular traps (NETs) and autoantibodies targeting myeloperoxidase (MPO) and neutrophil elastase (NE) in sputum by confocal microscopy

Thumbnail

D1.124 - Changes in respiratory infections patterns in Patients with Severe Asthma and a High burden of comorbidities treated with tezepelumab: interim analysis results of the T-ROSS II study

Thumbnail

D1.126 - Therapeutic Splenic Ultrasound Insonation as a Modulator of Pro-atherogenic and Pro-asthmatic Immune Inflammation: A Preclinical Study Design

Thumbnail

D1.128 - Use of Tezepelumab in four Patients with Allergic Bronchopulmonary Aspergillosis and severe uncontrolled Asthma: A Case Series

Thumbnail

D1.130 - Immune markers after one year treatment with benralizumab in severe eosinophilic asthma

Thumbnail

D1.131 - Unconventional Group 2 Innate Lymphoid Cells Expressing C-Kit and IL-17A are Increased in Sputum from Severe Asthma with Mixed Granulocytic Airway Inflammation

Thumbnail

D1.134 - Type 2 innate lymphoid cells promote development and differentiation of neonatal lung stem/progenitor activity

Thumbnail

D1.151 - Changes in Treatment Steps After Biological Therapy in Patients with Severe Asthma: Real-World Data

Thumbnail

D1.139 - Dupilumab was Effective in Black and Non-Black Patients with Asthma Completing 1 Year of the RAPID Registry

Thumbnail

D1.140 - Beyond Severe Asthma: Eosinophilic Granulomatosis with Polyangiitis Unmasked by Acute Myopericarditis

Thumbnail

D1.141 - Added value of impulse oscillometry in the early detection of small airway dysfunction in asthma

Thumbnail

D1.142 - Clinical remission in long-term biological therapy of severe asthma

Thumbnail

D1.143 - Clinical Efficacy of Biologics and ATAD in NSAID-Exacerbated Respiratory Disease: A Phenotype-Based Comparative Study

Thumbnail

D1.144 - Eosinophilic myocarditis as a complication of dupilumab treatment

Thumbnail

D1.145 - Clinical Impact of Type 2 Phenotype in Severe Asthma Patients with Exacerbations During Biologic Treatment

Thumbnail

D1.146 - Improved nocturnal oxygenation in a severe allergic asthma patient with comorbid sleep apnea under anti-TSLP biologic therapy

Thumbnail

D1.147 - Efficacy of benralizumab in Chinese patients with severe eosinophilic asthma: subgroup analysis of the 16-week results from STEP, a phase IIIb study of step-down maintenance therapy

Thumbnail

D1.148 - Real-world effectiveness of dupilumab administered every 4 weeks in patients with moderate to severe asthma